The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
Open accessAbstract
Apoptosis is crucial for the normal development of the nervous system, whereas neurons in the adult CNS are relatively resistant to this form of cell death. However, under pathological conditions, upregulation of death receptor family ligands, such as tumour necrosis factor (TNF), can sensitize cells in the CNS to apoptosis and a form of regulated necrotic cell death known as necroptosis that is mediated by receptor-interacting protein kinase 1 (RIPK1), RIPK3 and mixed lineage kinase domain-like protein (MLKL). Necroptosis promotes further cell death and neuroinflammation in the pathogenesis of several neurodegenerative diseases, including multiple sclerosis, amyotrophic lateral sclerosis, Parkinson disease and Alzheimer disease. In this Review, we outline the evidence implicating necroptosis in these neurological diseases and suggest that targeting RIPK1 might help to inhibit multiple cell death pathways and ameliorate neuroinflammation. Necroptosis is a form of cell death mediated by receptor-interacting protein kinase 1 (RIPK1), and is observed in several CNS disorders. Here, Yuan, Amin and Ofengeim give an overview of necroptosis in the CNS and explain its relationship with inflammation in CNS disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased activation of TNF/TNFR1 signalling following chronic activation of microglia can give rise to TNF-mediated necroptotic neuronal cell death, 160 which represents a possible therapeutic target in Parkinson's disease.161”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [161]
Experimental — accuracy not yet measuredIn the citing paper
“Yet, several genes that have been implicated in neuroinflammation38 (such as RIPK1) were seen specifically in microglial states associated with COVID-19.”
From Dysregulation of brain and choroid plexus cell types in severe COVID-19 (2021) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068
Self-citationInduction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Sun, L., Wang, H., Wang, Z., He, S., Chen, S., Liao, D., Wang, L., Yan, J., Liu, W., Lei, X., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.031 · Cited by 2,698
Ji, Y. (1993) · Cell · doi:10.1016/0092-8674(93)90485-9 · Cited by 2,497
Cho, Y., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M., & Chan, F. K.-M. (2009) · Cell · doi:10.1016/j.cell.2009.05.037 · Cited by 2,435
Kigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., & Popovich, P. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3257-09.2009 · Cited by 2,130
Identification of RIP1 kinase as a specific cellular target of necrostatins
Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I. L., Korkina, O., Teng, X., Abbott, D., Cuny, G. D., Yuan, C., Wagner, G., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.83 · Cited by 2,059
Self-citation
Cited by
Sorted by citations
Items 701–800 of 993
Hou, J. Y., Lu, Z., Dong, R., Wu, G., Nie, H.-B., Yang, G., Tang, C., Qu, G., & Xu, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.928204 · Cited by 3
Astrocytes: new stars in the medulloblastoma firmament
Eberhart, C. G. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa057 · Cited by 3
Repositioning linifanib as a potent anti-necroptosis agent for sepsisPreprint
Kai, Y., Li, M., Yu, L., & He, X. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.24.485557 · Cited by 3
Transcriptome analysis of long non-coding RNA and mRNA Profiles in VSV-infected BHK-21 Cells
Han, W., Fei, X., Yang, F., Sun, X., Yang, J., Qiu, J., Zhang, L., Zhang, W., Chen, G., Han, W., et al. (2024) · BMC Genomics · doi:10.1186/s12864-024-09991-9 · Cited by 2
Zhang, H., Zhang, L., Liang, X., Zhang, L., Ma, B., Li, Y., Wang, J., Shen, Y., Pang, Y., & Xiong, J. (2024) · Hereditas · doi:10.1186/s41065-024-00335-x · Cited by 2
Li, R. F., Huang, T., Zhou, J., Liu, X., Li, G., Zhang, Y., Guo, Y., Li, F., Li, Y., Liesz, A., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70144 · Cited by 2
Ma, L., Zhang, Y., Luo, Z., Zheng, L. T., Jiang, Y., Zou, M., Zheng, Y., Kong, L., & Wang, X. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117530 · Cited by 2
Lee, Y., Lee, C., Lee, Y., & Lee, Y.-J. (2025) · Life · doi:10.3390/life15060836 · Cited by 2
Cell deaths conversion regulates the development of Apostichopus japonicus skin ulceration syndrome
Shen, S., Shao, Y., & Li, C. (2025) · Aquaculture · doi:10.1016/j.aquaculture.2025.742893 · Cited by 2
Vijayan, R. S. K., Hamilton, M. M., Pfaffinger, D. E., Alvarez, F. G., Reyna, N. J., Bardenhagen, J., Shepard, H. E., Rodriguez, C., Goodwani, S., Lightfoot, Y. L., et al. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00317b · Cited by 2
Xiang, X.-N., Zhang, J.-Y., Wang, X.-X., He, H., & He, C. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1655579 · Cited by 2
Zhang, X., Yi, C., Liu, Y., Shi, Y., Zhang, M., Cui, Y., Yang, X., Wang, Y., Chen, J., & Li, X. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.119137 · Cited by 2
Mahale, A. B., Regula, S., Chanchlani, B., Ghosh, B., & Kulkarni, O. P. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115634 · Cited by 2
Liu, J., Ma, A., Huang, G., Hu, W., Xu, X. Y., Huang, R., Hu, Y., Cheng, Q., Feng, Y., Ye, D., et al. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02429-1 · Cited by 2
Targeting the MLKL–F-actin–NLRP3 axis attenuates arsenic-induced myocardial necroinflammation
Liu, Y., Cui, Y., Zhang, M., Shi, Y., Zhao, X., Zhang, X., Li, L., Yang, P., & Chen, J. (2025) · Food and Chemical Toxicology · doi:10.1016/j.fct.2025.115861 · Cited by 2
Targeting RIPK1 to modulate cell death and tumour microenvironment in cancer therapy
Chen, J., Mao, S., Huang, L., Zhu, T., & Bei, Y. (2025) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2025.2593800 · Cited by 3
O-GlcNAcylation in novel regulated cell death: ferroptosis, pyroptosis, and necroptosis
Wang, Y., Zhao, H., Nyima, T., & Ma, Z. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02895-x · Cited by 2
Rong, Z., Liu, T., & Wei, J. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112288 · Cited by 2
Targeting autophagy and programmed cell death in neurological diseases via probiotic intervention
Chen, L., Sabihi, S.-S., & Zhang, C. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00787-0 · Cited by 2
Wang, Z., Zhang, R., Dai, D., Zhang, M., Gao, D., Zhang, J., Wu, Z., Hui, K., Xiong, J., Cheng, H., et al. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116182 · Cited by 3
Li, T., Su, T., Tang, S., Cao, K., Hua, P., Gao, J., Cui, H., & Jiang, T. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102060 · Cited by 3
From knowledge landscapes to network mechanisms: charting regulated cell death pathways in ALS
Zhang, J., Zhao, Z., Xiang, T., Teng, D., Wan, H., Zhang, Q., & Liu, X. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1742805 · Cited by 2
Targeting non-apoptotic regulated cell death (RCD) to treat neurodegenerative diseases
Zhao, W., Lai, Y., Li, Z., Yuan, Z., Wen, Z., & Zhang, L. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.01.040 · Cited by 3
Shu, Y., Ding, Z.-H., Gao, P.-P., An, Q., Wu, L.-C., Zhang, X.-R., Jiang, H., Miao, C., Peng, M.-T., Chen, X., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1745656 · Cited by 3
Akinduko, A., Salawu, S. O., Akinmoladun, A. C., Nwonuma, C. O., Akindahunsi, A. A., Oniyiku, R. T., Mustapha, S., Uzoka, U. H., & Ugwor, E. I. (2026) · In Silico Pharmacology · doi:10.1007/s40203-026-00557-z · Cited by 2
Guo, S., Jin, H., Sun, H., Huang, S., Chen, Y., Chang, Y., Zhang, Y., Ding, L., Chen, S., Fu, C., et al. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-026-00394-9 · Cited by 3
Yi, S., Zou, J., Xiaofei, H. E., Chen, H., Lin, Z., Zhang, L., Zhu, Y., Zuo, Z., Chen, Z., Hu, X., et al. (2026) · Research · doi:10.34133/research.1244 · Cited by 2
Qiu, J., Liao, Y., Kan, D., Liao, L., Yang, K., Hu, X., Wang, Z., Yu, H., Xie, F., & Liu, Z. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s587972 · Cited by 2
Xia, Y., Xie, R., Huo, X., Chen, K., Li, S., Xu, S., & Li, S. (2026) · Redox Report · doi:10.1080/13510002.2026.2663621 · Cited by 2
Regulatory complexity and therapeutic targeting of the necroptosis network
Niu, L., Liu, F., Zhao, Y., Li, J. Q., & Wang, H. B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1824460 · Cited by 2
Toklucu, E. S., Shen, S., Wang, C., & Zhang, C. (2026) · Biomedicines · doi:10.3390/biomedicines14051155 · Cited by 2
A computational study to target necroptosis via RIPK1 inhibition
Bepari, A. K., Takebayashi, H., Namme, J. N., Rahman, G. M. S., & Reza, H. M. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2108900 · Cited by 3
Deng, Y., Lin, Y., Zhou, B., Qian, J., & Zhang, W. J. (2023) · Current Cancer Drug Targets · doi:10.2174/1568009623666230414140609 · Cited by 2
Yamazaki, M., YAMADA, H., Munetsuna, E., Ando, Y., Kageyama, I., Sadamoto, N., Nouchi, Y., Teshigawara, A., Mizuno, G., Ishikawa, H., et al. (2023) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.69.237 · Cited by 2
Targeting Acid-Sensing Ion Channels in Disease
Senescall, V., Budusan, E., Knezic, A., Waqar, M., Butcher, N. J., Khan, N., McCarthy, C. A., Widopp, R., Karatt-Vellatt, A., & Rash, L. D. (2024) · Springer eBooks · doi:10.1007/978-3-031-52197-3_10 · Cited by 2
Emerging Microglial Therapies and Targets in Clinical Trial
Yan, L., & Crotti, A. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_35 · Cited by 2
Integrating necroptosis into pan-cancer immunotherapy: a new era of personalized treatment
Gao, Y. Q., Chen, S., & Li, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1510079 · Cited by 2
Wang, X., Wang, T., Zhu, D., Wang, J., & Han, W. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae105 · Cited by 2
Jana, S., Maqbool, M., Yan, X., Jakobsson, J. E., Lee, A. C., Liow, J., Zoghbi, S. S., Wu, S., Long, P., Innis, R. B., et al. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00715 · Cited by 2
Wang, P., Niu, T., Huang, D., Li, Y., Jiang, Z., Wang, X., & Liao, L. (2025) · Toxicology · doi:10.1016/j.tox.2025.154102 · Cited by 3
Li, M., Shi, Y., He, X., Wang, S.-C., Liu, J., Wang, Z., Dang, H., & Yu, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083608 · Cited by 2
Li, X., Yang, S., Zhang, H.-J., Zhong, Y., Wen, G., Kang, X., & Xiao, Z. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120146 · Cited by 3
Liu, X., Li, G., Guo, Y., Li, R., Yi, S., Ding, S., & Wan, J. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115370 · Cited by 2
Liu, J., Li, H., Qu, Y., Li, S., & Zhao, F. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04484-x · Cited by 2
Shao, X., Feng, X., Feng, J., Qiu, T., Yang, S., & Li, Q. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147438 · Cited by 2
Revue de la littérature sur les maladies auto-inflammatoires associées aux mutations du gène RIPK1
Parentelli, A.-S., Pïcard, C., Boursier, G., Melki, I., Bélot, A., Smahi, A., & Georgin‐Lavialle, S. (2022) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2022.06.005 · Cited by 2
Maghsoudi, A., Zaringhalam, J., Moosavi, M., & Eidi, A. (2021) · Physiology and Pharmacology · doi:10.52547/phypha.26.4.1 · Cited by 2
Necroptosis plays a crucial role in the exacerbation of retinal injury after blunt ocular trauma
Huan, Y., Wu, X.-Q., Chen, T., Dou, Y.-N., Jia, B., He, X., Wei, D.-Y., Fei, Z., & Fei, F. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.353848 · Cited by 2
Smith, F. (2022) · Springer eBooks · doi:10.1007/978-3-031-13388-6_8 · Cited by 2
Lan, Y., Ji, Y., Peng, X., Duan, W., Geng, M., Ai, J., & Zhang, H. (2024) · Archiv der Pharmazie · doi:10.1002/ardp.202400302 · Cited by 2
Par-4 in Neuronal Death and Survival in Alzheimer’s Disease and Other Neurogenerative Diseases
Guo, Q., Xie, J., & Guo, C. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-80558-6_14 · Cited by 2
Salvadores, N., Moreno‐González, I., Gamez, N., Quiroz, G., Vegas, L., Escandón, M., Jiménez, S., Vitórica, J., Gutiérrez, A., Soto, C. A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.27.457960 · Cited by 2
Janakiraman, U., Larson, K., Nixon-Lee, N., Damon, M., Biscardi, A., Hawkins, E., Deshpande, L. S., & Dixon, K. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.28.518204 · Cited by 2
Fan, Y., Wu, H., Xiong, L., Luo, F., Li, Q., Wang, D., & Zhong, T. (2022) · Fitoterapia · doi:10.1016/j.fitote.2022.105314 · Cited by 1
Wang, X., Deng, K., Tao, J., Zou, J., Du, Y., & Dai, L. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03139-7 · Cited by 2
Li, X., Chen, M., Xu, B., Fan, Y., Dai, C., & Dong, Z. (2024) · Pediatric Discovery · doi:10.1002/pdi3.66 · Cited by 1
Zhao, H. L., Wang, C., Liu, B., Weng, Z., Shi, Y., & Zhang, C. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-10080-z · Cited by 1
Cell Death Pathways: Intricate Connections and Disease Implications
Halder, S., & Jana, K. (2024) · Springer eBooks · doi:10.1007/978-981-97-7905-5_1 · Cited by 1
Reduction of intestinal RIPK1 ameliorates HFD-induced metabolic disorders in female mice
Yuan, Y., Hu, X., Guo, C., Xu, Y., Li, S., Wen, W., Hu, X., Zeng, F., Cui, W., Chen, W., et al. (2025) · iScience · doi:10.1016/j.isci.2025.111906 · Cited by 1
ATR-mediated phosphorylation of RIPK1 inhibits DNA damage-induced necroptosis
Shi, S.-N., Xu, Q., Jiao, X., Wen, Y., Wu, Y., Liu, J., Ma, D., Zhao, B., Gao, Q., & Fang, Y. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117069 · Cited by 1
Elucidating the mechanistic role of Rip3 in post-thalamic hemorrhage neurological deficits
Xiao, Y., Li, Y., Zhang, Y., Ge, Y., Han, S., Wang, Z., Gao, J., & Huang, T. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115373 · Cited by 1
Torres, A., Díaz, L., Muñoz, J. A. O., Michea, M. A., Xu, X., Salazar‐Onfray, F., & González, F. E. (2025) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2025.08.001 · Cited by 1
Zhang, X., Xu, T., Zhu, J., Peng, H., Wei, Z., Cui, L., Zuo, Q., Liu, H., Hu, Y., & Cao, J. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0013428 · Cited by 1
Advanced regenerative biomaterials for ischaemic stroke: a comprehensive therapeutic strategy
Niu, S., Liu, X., Wu, Z., Zhu, A., Zhang, Y., Hu, F., Ding, K., Wu, J., & Xiao, A. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb01227a · Cited by 1
Yang, J., Xiao, C., Yi, M., Zhou, K., Xu, X., & Fan, Y. (2025) · Stroke and Vascular Neurology · doi:10.1136/svn-2025-004469 · Cited by 1
Li, H., Qin, Z., Zhou, Y., Meng, H., Xie, W., Pan, Y., Yang, X., Cai, H., Li, L., Wang, C., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02770 · Cited by 1
Necroptosis Inhibition Preserves Diaphragm Function in Experimental Sepsis
Fu, X., Wang, L., Xu, Q., Yao, H., Xia, X.-X., Wang, Y., Li, T.-L., Yao, Z.-W., Luo, J., Liang, G., et al. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.08.013 · Cited by 1
Fatty acid metabolic dysfunction in Parkinson's disease
Rathor, P., & Ch, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33296-8.00019-8 · Cited by 1
Wu, Z., Zhao, J., Wang, W., Dong, Y., Zhou, T., Feng, Y., Deng, Y., & Feng, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1714796 · Cited by 1
Lear, B. A., McDouall, A., Lear, O. J., Dhillon, S. K., Lear, C. A., Northington, F. J., Bennet, L., & Gunn, A. J. (2025) · Cells · doi:10.3390/cells14241984 · Cited by 1
Zhu, Z.-Y., Lin, X., Kong, F., Wang, Z., Liang, Y., Ji, C., Chen, H., Sun, K., Wang, C., Xu, X., et al. (2026) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2025.101039 · Cited by 1
Receptor-Interacting Protein Kinase 1 (RIPK1): A Potential Therapeutic Target in Ischemic Stroke
Liu, Z., Xu, F., Wang, Z., Zhang, Y., Zhao, Y., & Fang, W. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05661-x · Cited by 1
Seo, H., Haseeb, M., & Choi, S. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117727 · Cited by 1
Zeng, M., Zhou, H., Zeng, L., zhang, M., Yang, J., Geng, W., & Wan, H. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111747 · Cited by 1
Zou, J., Gao, X., Chen, J., Zhou, B., Meng, X., Chen, J., Huang, P., & Cao, H. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106478 · Cited by 1
Du, Y., Li, J., Zhao, C., Hou, S., Li, Q., Xu, X., Li, Z., Qiu, J., Zhuang, C., Xie, L., et al. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-02962-x · Cited by 1
Folarin, R. O., Olopade, F. E., Gilbert, T. T., Ladagu, A. D., dos Santos, P. I. P., Mustapha, O., Kpasham, L. Z., Outeiro, T. F., & Olopade, J. O. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01811-1 · Cited by 1
Udaiyappan, J. P., Balakrishnan, R., Tamilarasan, M. M., Balasubramanian, B., & Abass, K. S. (2026) · Inflammation · doi:10.1007/s10753-026-02492-9 · Cited by 3
Bacillus cereus Induces Necroptosis in Microglia via the RIPK1/3‐MLKL Pathway
Yang, J., Sun, B., Xu, H., Shen, Y., Ye, H., Yuan, Q., Chen, S., & Zheng, M. (2026) · MicrobiologyOpen · doi:10.1002/mbo3.70276 · Cited by 1
Targeting Inflammatory Cell Death: A Strategy for Discogenic Pain Relief
Wang, L., Zhang, Y., Tao, H., Jiang, C., Chen, W., Chen, T., Luo, R., Wang, Y., Dong, J., Hu, X., et al. (2026) · Journal of Pain Research · doi:10.2147/jpr.s583691 · Cited by 1
Biscetti, L., Gambuzza, M. E., Princiotto, M., Sabbatinelli, J., Olivieri, F., Fiorillo, M., Chinigò, C., Muglia, L., Cozza, A., Beccacece, A., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119326 · Cited by 2
Pan, J., & Yang, H. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1762900 · Cited by 1
Cell death in uveitis: pyroptosis, ferroptosis, apoptosis, and beyond
Liu, J., Mao, L., Chen, G., Zou, L., Shi, Y., Jiang, L., & Meng, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1751523 · Cited by 1
Design, synthesis and anti-necroptosis evaluation of RIPK1 inhibitors derived from sunitinib
Jiang, Y., Zheng, Y., Zou, M., Zheng, L., Luo, Z., Kong, L., & Wang, X. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118925 · Cited by 1
PTBP1: A master regulator of neural development and transdifferentiation—promise and pitfalls
Liu, Y., Huang, Y., Wang, Y., Mao, M., & Huang, M. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153948 · Cited by 1
Kolinko, Y. (2026) · Contemporary clinical neuroscience · doi:10.1007/978-3-032-18296-8_11 · Cited by 1
Li, N., Zhang, H., Peng, L., Liu, J., Lin, G., Sun, J., Li, W., Hu, J., & Tang, J. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118094 · Cited by 1
Targeting RIPK1 is a promising therapeutic avenue for systemic lupus erythematosus
Chen, M., Wan, L., Wang, M., Liang, J., Ke, Y., Jiang, M., Liu, J., & Cao, H. (2026) · Clinical Rheumatology · doi:10.1007/s10067-026-08080-4 · Cited by 1
Vari, H. R., & Praticò, D. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-09035-y · Cited by 1
Chen, J. Z., Zhu, L., Huang, W., Wang, Z. W., Gao, Y., Fan, M., Hongyang, Q., Bao, H., Zeng, C., Wang, F., et al. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.122116 · Cited by 1
Xu, C., Ke, C., Zhong, Y.-L., Yang, X.-H., Wang, M.-M., Cao, Y., & Chen, J. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103225 · Cited by 1
Mechanism and regulation of programmed cell death in aging-related diseases
Xie, X., & Xu, D. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2026.06.005 · Cited by 1
Mechanisms of neurotoxicity of fluoride or aluminum: implications for neurodegenerative disease risk
Wang, Z.-L., Baker, T. R., & Malin, A. J. (2026) · Current Research in Toxicology · doi:10.1016/j.crtox.2026.100313 · Cited by 1
Mechanisms, regulation and clinical relevance of necroptosis
Yang, Y., Jiao, H., & Xu, D. (2026) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-026-01002-x · Cited by 2
Discovery and Development of First-in-Class Cereblon-Recruiting RIPK1 Degraders
Lu, D., Yu, X., Lin, H., Cheng, R., Zhang, M., Yang, B., Chen, J., Li, F., Qi, X., & Wang, J. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01156 · Cited by 1
Target Validation—Prosecuting the Target
Jones, L. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00014-1 · Cited by 1
Du, L., Wu, Y., Pan, Y., Wang, L., Zhang, H., Liu, Y., Liu, Y., Zhang, H., & He, P. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad151 · Cited by 1
RECENT DEVELOPMENTS IN THE DISCOVERY OF BRAIN-PENETRANT RIP1 INHIBITORS
Stivala, C. E., & Vucic, D. (2023) · Medicinal chemistry reviews · doi:10.1021/mc-2023-vol58.ch04 · Cited by 1
Wang, J., Lu, C., Wang, J., Wang, Y., Bi, H., Zheng, J., & Ding, X. (2023) · Genomics · doi:10.1016/j.ygeno.2023.110778 · Cited by 1
The role of autophagy in RIP1 mediated cell death and intestinal inflammation
Lee, Y. M., & Vucic, D. (2024) · Advances in immunology · doi:10.1016/bs.ai.2024.07.003 · Cited by 2
Metadata
- Authors
- Yuan, J., Amin, P., & Ofengeim, D.
- Affiliations
- Harvard University (US)
- Sanofi (United States) (US)
- Corresponding author
- Yuan, Junying
- Venue
- Nature Reviews Neuroscience
- Published
- 2018-11-22
- Volume
- 20
- Issue
- 1
- Pages
- 19-33
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- PMC
- PMC6342007
- OpenAlex
- W2901410206
- Semantic Scholar
- a6626d511f6ce29e1ffd0f9740b5c693cadb4fb3
- Cited by
- 967
- References
- 179
- Citations by year
- 2026: 110 · 2025: 156 · 2024: 149 · 2023: 152 · 2022: 164 · 2021: 134 · 2020: 65 · 2019: 35
- FWCI
- 5.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Denali Therapeutics
- National Institutes of Health (4r01ns082257-04)
- National Institute on Aging (RF1AG055521, R01AG047231, R21AG059073)
- National Institute of Neurological Disorders and Stroke (R01-NS082257)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- necroptosis, RIPK1, neuroinflammation, RIPK3, MLKL, apoptosis, TNF-α, death receptor ligands, neurodegenerative diseases, multiple sclerosis, amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, central nervous system disorders
- MeSH terms
- Necroptosis, Animals, Brain, Humans, Inflammation, Neurons, Phosphorylation, Neurodegenerative Diseases, Receptor-Interacting Protein Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review